ARCHIVES

Guest Editorial: Myriad Ruling Becomes a Textbook Case Of How Not To Manage a Patent Portfolio, by Robert Cook-Deegan

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: IOM Study Welcome For “Omic” Research

October 29, 2010

Deflecting Earmarks, NCI Advisors Lay Out Research Opportunities In Breast, Prostate

February 26, 1999

NCI-Approved Clinical Trials Listed For June 2001

July 27, 2001

Cholesterol-Lowering Drugs May Prevent Breast Cancer

October 31, 2003

NCI Says More Phase Trials Needed In Cancer Prevention, Nutrition

April 18, 1986

Studies Seek to Identify High-Risk Groups to Justify Mammography Screening at 40

May 4, 2012